| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.095 | 0.02 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.02 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.099 | 0.02 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.03 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.069 | 0.03 |